Patent Application
Utility
App. No. 17/515,985
· Confirmation No. 8758
METHOD FOR EX-VIVO EXPANSION OF REGULATORY T CELLS WITH ENHANCED SUPPRESSIVE FUNCTION FOR CLINICAL APPLICATION IN IMMUNE MEDIATED DISEASES
Applicant:
Mallinckrodt Pharmaceuticals Ireland Limited
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2025-08-14 | OATH |
Oath or Declaration filed | 75 | View | |
| 2024-06-28 | ABN |
Abandonment | 2 | View | |
| 2024-02-22 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2024-02-22 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-01-11 | CTAV |
Advisory Action (PTOL-303) | 3 | View | |
| 2024-01-11 | A.NE.AFCP.D |
After Final Consideration Program Decision | 1 | View | |
| 2024-01-11 | ANE.I |
Amendment After Final or under 37CFR 1.312, initialed by the examiner. | 1 | View | |
| 2023-12-26 | A.NE |
Response After Final Action | — | View | |
| 2023-12-26 | A.NE.AFCP |
After Final Consideration Program Request | 2 | View | |
| 2023-12-26 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2023-12-26 | A.NE |
Response After Final Action | 1 | View | |
| 2023-12-26 | CLM |
Claims | 2 | View | |
| 2023-12-26 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2023-12-26 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2023-10-26 | CTFR |
Final Rejection | 10 | View | |
| 2023-10-26 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2023-10-26 | SRNT |
Examiner's search strategy and results | 21 | View | |
| 2023-07-28 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2023-07-26 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 1 | View | |
| 2023-07-26 | CLM |
Claims | 2 | View | |
| 2023-07-26 | REM |
Applicant Arguments/Remarks Made in an Amendment | 4 | View | |
| 2023-07-26 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2023-04-26 | CTNF |
Non-Final Rejection | 16 | View | |
| 2023-04-26 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2023-04-26 | 1449 |
List of References cited by applicant and considered by examiner | 6 | View | |
| 2023-04-26 | SRNT |
Examiner's search strategy and results | 13 | View | |
| 2023-04-26 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2023-03-23 | ELC. |
Response to Election / Restriction Filed | 1 | View | |
| 2023-03-23 | CLM |
Claims | 2 | View | |
| 2023-03-23 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2023-03-23 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2023-03-23 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2023-03-02 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 6 | View | |
| 2023-03-02 | FOR |
Foreign Reference | 75 | View | |
| 2023-03-02 | FOR |
Foreign Reference | 40 | View | |
| 2023-03-02 | FOR |
Foreign Reference | 30 | View | |
| 2023-03-02 | FOR |
Foreign Reference | 24 | View | |
| 2023-03-02 | FOR |
Foreign Reference | 96 | View | |
| 2023-03-02 | N417 |
Electronic Filing System Acknowledgment Receipt | 5 | View | |
| 2023-02-09 | CTRS |
Requirement for Restriction/Election | 5 | View | |
| 2022-02-24 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2021-11-15 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2021-11-15 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2021-11-01 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View | |
| 2021-11-01 | PA.. |
Power of Attorney | 1 | View | |
| 2021-11-01 | OATH |
Oath or Declaration filed | 2 | View | |
| 2021-11-01 | ABST |
Abstract | 1 | View | |
| 2021-11-01 | DRW.NONBW |
Drawings-other than black and white line drawings | 5 | View | |
| 2021-11-01 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2021-11-01 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2021-11-01 | ADS |
Application Data Sheet | 8 | View | |
| 2021-11-01 | CLM |
Claims | 2 | View | |
| 2021-11-01 | SPEC |
Specification | 7 | View | |
| 2021-11-01 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View |
Inventors
Tinghua Cao
Malvern, PA
Li Li
Downington, PA
Attorneys & Agents of Record
Classification
USPC
424/184.1
C12N5/0637
A61K40/416
A61K40/22
A61K40/11
A61K2035/122
C12N5/0636
C12N2501/23
C12N2501/2302
C12N2501/51
C12N2501/515
Prosecution
- Examiner
- ZEMAN, ROBERT A
- Art Unit
- 1645
- Customer No.
- 24289
- Docket No.
- H-TK-00031US DIV1(706120)
- Confirmation No.
- 8758
Publication
- Pub. No.
- US20220056410A1
- Pub. Date
- 2022-02-24
Parent
is a Division of
→
App. 15/981,332
· US 11,186,823
Filed 2018-05-16
· Patented Case
Parent
is a Continuation of
→
App. 15/094,467
Filed 2016-04-08
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 12/781,451
Filed 2010-05-17
· Abandoned -- Failure to Respond to an Office Action
Parent
Claims priority from a provisional application
→
App. 61/179,165
Filed 2009-05-18
· Provisional Application Expired
Child
is a Continuation of
→
App. 18/584,070
· US 12,421,494
Filed 2024-02-22
· Patented Case
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
OCERA THERAPEUTICS LLC,
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC
RELEASE OF SECURITY INTEREST
Recorded 2025-08-14
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
SPECGX LLC,
OCERA THERAPEUTICS, INC.,
STRATATECH CORPORATION,
VTESSE LLC,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
SUCAMPO PHARMA AMERICAS LLC
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 060434, FRAME 0536
Recorded 2023-11-16
OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.),
MALLINCKRODT LLC,
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY,
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
RELEASE OF SECURITY INTERESTS IN PATENTS AT REEL 060389/FRAME 0913
Recorded 2023-11-15
from
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
OCERA THERAPEUTICS LLC,
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC
SECURITY INTEREST
Recorded 2023-11-15
from
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
OCERA THERAPEUTICS, INC.,
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY
Recorded 2022-06-22
from
MALLINCKRODT ENTERPRISES LLC,
MALLINCKRODT LLC,
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED,
OCERA THERAPEUTICS, INC.,
SPECGX LLC,
STRATATECH CORPORATION,
SUCAMPO PHARMA AMERICAS LLC,
VTESSE LLC
SECURITY INTEREST
Recorded 2022-06-17
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 17/515,985
- Filed
- 2021-11-01
- Pub. No.
- US20220056410A1
- Examiner
- ZEMAN, ROBERT A
- Art Unit
- 1645
External Links